Presence of enteric hepatitis viruses in the sewage and population of Greater Cairo  by Kamel, A.H. et al.
8. Braito A, Corbisero R, Corradini S et al. Evidence of Toscana virus
infection without central nervous system involvement: a serological
study. Eur J Epidemiol 1997; 13: 761–764.
9. Clarke DH, Casals J. Techniques for hemagglutination and hemaggluti-
nation-inhibition with arthropod-borne viruses. Am J Trop Med Hyg
1958; 7: 561–573.
10. Venturi G, Mel R, Marchi A et al. Humoral immunity and correlation
between ELISA, hemagglutination inhibition, and neutralization tests
after vaccination against tick-borne encephalitis virus in children.
J Virol Methods 2006; 134: 136–139.
11. Ergu¨nay K, Saygan MB, Aydog˘an S et al. Sandﬂy fever virus activity in
Central/Northern Anatolia, Turkey: ﬁrst report of Toscana virus
infections. Clin Microbiol Infect 2010; doi: 10.1111/J.1469-0691.
2010.03346.x [Epub ahead of print].
12. Madic´ J, Savini G, Di Gennaro A et al. Serological evidence for
West Nile virus infection in horses in Croatia. Vet Rec 2007; 160:
772–773.
Presence of enteric hepatitis viruses in the
sewage and population of Greater Cairo
A. H. Kamel1,2, M. A. Ali2, H. G. El-Nady3, A. Deraz4,
S. Aho5, P. Pothier1 and G. Belliot1
1) Laboratory of Virology, National Reference Centre for Enteric Viruses, P-
ublic Hospital of Dijon, Dijon, France, 2) Laboratory of
Virology, Infectious Diseases and Immunology Group, Centre of
Excellence for Advanced Sciences, 3) Child Health Department,
Medical Division, National Research Centre, Dokki, Cairo, 4) Laboratory of
Virology, Embaba Fever Hospital, Giza, Egypt and 5) Epidemiology and
Infection Control Unit, Public Hospital of Dijon, Dijon, France
Abstract
In Egypt, the disease burden of viral hepatitis is one of the heavi-
est worldwide. We conducted a survey of hepatitis A virus
(HAV) and hepatitis E virus (HEV) in patients and sewage in
Cairo. Our data showed that HAV (genotype IB) was predomi-
nant over HEV (genotype 3) and was circulating in the popula-
tion and the environment.
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Hepatitis A virus (HAV) comprises a single serotype and
seven genotypes. In Africa and the Middle East, the HAV
strains mostly belong to genotypes IA and IB [1–3]. HAV is
primarily transmitted by the faecal–oral route. HAV is one of
the most resistant enteric viruses in the environment [4].
Hepatitis E virus (HEV) is classiﬁed into four genotypes, 1–4,
the distribution of which varies around the world [5]. The
disease burden of HEV is high in developing countries, where
it causes waterborne outbreaks as well as sporadic hepatitis
[5]. Little is known about HEV in the environment. In our
study, we performed a molecular survey of both viruses in
patients suffering from hepatitis and in sewage collected from
two waste water treatment plants (WWTPs) of Greater
Cairo.
Fifty stool samples were collected from patients with hep-
atitis hospitalized at the Embaba Fever Hospital in Cairo dur-
ing July and August 2007. The patients were between
1.5 years and 15 years of age (mean 5.4 years), and pre-
sented hepatitis-related symptoms. The level of bilirubin was
evaluated for each patient. The stool specimens were col-
lected up to the 16th day after the onset, and were screened
for HAV and HEV. The viruses were quantiﬁed with real-
time RT-PCR: the stool specimens were weighed prior to
extraction of the RNA [6].
We collected 76 samples of raw and treated sewage (4 L
of each) from two WWTPs, located at Zenin and El-Berka in
Greater Cairo, between July 2006 and August 2007. The
characteristics of both WWTPs and the sampling procedure
from July 2006 through February 2007 have been docu-
mented [7]. For July and August 2007, the raw and treated
sewage was collected twice during the ﬁrst and last weeks of
the month. Enteroviruses and HAV were concentrated from
2 L of sewage as described previously [8]. The viral particles
were concentrated in 3 mL of 0.15 M Na2HPO4 (pH 7.4).
The remaining 2 L of sewage were decanted prior to
concentration of the HEV particles by adsorption/elution as
described previously [9]. Viral particles were resuspended in
4 mL of McIlvaine buffer (pH 5) [10]. One millilitre was used
for the extraction of the nucleic acids [6].
Three microlitres and 10 lL of RNA were used for the
detection of HAV in the clinical and environmental samples,
respectively, by RT-PCR with primers H1 and H2 [11]. For
the environmental samples, the results were conﬁrmed by
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semi-nested PCR with primers H2 and H3 and 1 lL of PCR
product. HAV-positive samples were analysed by real-time
RT-PCR in triplicate assays [12]. The copy number of the
HAV genomic RNA was determined from a standard curve
generated with serial dilutions of a plasmid construct of a
portion of the 5¢-non-coding region of the HM-175 strain
ampliﬁed with the forward (5¢-ATGGTGAGGGGACTTGAT
ACC-3¢) and reverse (5¢-GCATATGTATGGTATCTCAAC-3¢)
primers. Ten microlitres of RNA was used for the detection
of HEV in the clinical and environmental samples by nested
RT-PCR [13]. Additionally, the samples were screened for
the presence of HEV by three nested RT-PCRs with primers
targeting the ORF1, ORF2 and ORF2/3 regions [14]. The
presence of human enteroviruses has already been docu-
mented [7]. HAV and HEV were genotyped after sequencing
of the PCR product. The HAV viral load (dependent vari-
able) in combination with independent variables (date of col-
lection after onset, bilirubin level and patient age) were
modelled with the use of multiple linear regression. Compa-
risons of percentages were performed with Fisher’s exact
test (e.g. enterovirus–HAV association). The analyses were
performed with the STATA package (Stata Corp LP, College
Station, TX, USA).
Among the 50 individuals with hepatitis, a higher than nor-
mal level of bilirubin was detected up to 10 days post-onset
for 36 of 39 patients (Table 1). For the remaining 11 patients,
the samples were taken on the 15th day and 16th day after the
onset, and the bilirubin levels were normal. HAV was detected
in 70% (n = 35) of the stool specimens from the patients pre-
senting abnormal bilirubin levels. The HAV isolates all
belonged to genotype IB. The viral load varied between
4.1 · 103 and 1.7 · 108 genome copies per gram of stool
(Table 1). HAV was no longer detected in stools 2 weeks after
the onset. The age of the patients was not related to the viral
load or the bilirubin level (p >0.05). The association between
the viral load, the collection date and the bilirubin concentra-
tion was highly signiﬁcant (p 0.003, multiple linear regression
model). One genotype 3 HEV isolate (GenBank
no. GU353342) was detected in samples from a 9-year-old
patient. The stool specimen was positive with primers target-
ing the ORF2/ORF3 overlapping region, and negative with
other primer sets and by real-time RT-PCR.
HAV was detected by RT-PCR in 11 of 76 (15%) sewage
samples (Table 2). RNA was tested undiluted and at a ten-
fold dilution. Positive results were obtained for undiluted
RNA preparations only, suggesting the efﬁcient removal of
PCR inhibitors. The sewage isolates belonged to genotype IB,
based on partial sequencing of the VP3–VP1 capsid protein,
and were similar to the clinical isolates and the newly
described genotype IB variant [15]. The HAV-positive sam-
ples were also positive for enteroviruses (p <0.0001, Fisher’s
exact test). For the two WWTPs, there was a reduction in
the viral load between the inlet and the outlet. However,
the reduction was not statistically signiﬁcant for either
WWTP. HAV was detected by real-time RT-PCR in eight of
11 samples. The mean viral loads were 4.85 (N = 6) and 2.55
(N = 2) log of genome copies/L for the inlet and the outlet,
respectively. For the EB1 and EB2 samples collected in
August and September 2006, respectively, HAV was detected
in the inﬂuent and the efﬂuent of El-Berka during the same
day with a 3 log titre reduction (EB3 and EB7; Table 2). All
sewage samples were negative for HEV virus by conventional
and real-time RT-PCR (data not shown).
The disease burden of hepatitis A and E in Egypt is one of
the heaviest worldwide. HAV infection occurs very early in
life, with almost 100% seropositivity after the ﬁrst years of
life. In our study using direct detection of the viruses in
stool specimens, HAV (N = 35) was largely predominant
TABLE 1. Hepatitis A virus (HAV)-positive and hepatitis E
virus (HEV)-positive stool samples from acute hepatitis
cases
Isolate
Age
(years)
Collection
daya
Bilirubin
(mg/dL)
HAV
genotypeb
HAV viral
loadc (log copy
no./g ± SD)
July 2007
H1 9 7 3.6 IB 3.8 ± 0.3
H2 5.5 2 8.9 IB 7.4 ± 0.2
H3 15 1 17 IB 6.2 ± 0.1
H4 6 1 19 IB 8.1 ± 0.1
H5 4 6 3.6 IB 5.4 ± 0.4
H6 12 3 7.5 IB 6.4 ± 0.4
H7 5 7 3.6 IB 6.1 ± 0.1
H8 14 6 5.9 IB 6.1 ± 0.1
H9 14 4 6.6 IB 3.9 ± 0.1
H10 11 4 6.6 IB 5.6 ± 0.0
H11 2 4 6.1 IB 5.7 ± 0.2
H12 2 2 8 IB 5.5 ± 0.1
H13 10 1 3.6 IB 5.1 ± 0.4
H14 3 5 17 IB 6.1 ± 0.1
H15 5 1 17 IB 8.2 ± 0.2
H16 4.5 1 19 IB 7.6 ± 0.2
H17 4 1 17 IB 6.8 ± 0.0
H18 4 7 6.6 IB 5.5 ± 0.2
August 2007
H19 6 2 17 IB 6.2 ± 0.3
H20 8 5 19 IB 5.9 ± 0.0
H21 2 8 17 IB 5.0 ± 0.0
H22 2 1 6.6 IB 5.7 ± 0.1
H23 3 10 3.6 IB 4.8 ± 0.1
H24 3 7 8 IB 5.8 ± 0.1
H25 3 1 19.6 IB 5.7 ± 0.0
H26 6 6 5.2 IB 4.7 ± 0.1
H27 4 7 5.7 IB 6.3 ± 0.3
H28 4 4 6 IB 5.6 ± 0.1
H29 9 4 6.1 Negative Negative
H30 12 8 4.7 IB 4.5 ± 0.1
H31 1.5 10 3.6 IB 3.6 ± 0.1
H32 6 2 8 IB 5.6 ± 0.3
H33 3 5 3.6 IB 5.3 ± 0.1
H34 3 2 8.1 IB 6.9 ± 0.1
H35 3 3 6.5 IB 7.1 ± 0.1
H36 2 3 6.6 IB 6.0 ± 0.1
SD, standard deviation.
aTime between symptom onset and sample collection.
bGenotype 3 HEV was detected in stool samples from case 29.
cThe viral load is given per gram of stool.
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over HEV (N = 1). HAV from this study belonged to the
predominant IB genotype, as described previously [2,3]. The
high predominance of HAV in stool specimens correlates
with previous studies showing almost 100% HAV seropreva-
lence in older infants [16]. Nevertheless, it is interesting to
note that older children (e.g. 10 years of age and above)
could still suffer from hepatitis A. We also showed that
HAV could be excreted at a very high titre in stool speci-
mens, reaching 8 log genome per gram of stool during the
ﬁrst days after onset, which poses the threat of accidental
contamination of the water system. Our sewage survey con-
ﬁrmed that large quantities of HAV could be found, and a
substantial quantity passed through the treatment and might
still have been infectious at the outlet. It is of note that,
despite the fact that we could not determine whether HAV
from WWTP efﬂuents might be the source of contamination
of the population, partial sequencing of the VP1 protein sug-
gested that similar isolates were circulating throughout the
Cairo conurbation. Future studies should focus on ground
and surface water to assess the presence of HAV in the
environment.
The high prevalence of HEV in the Middle East was mostly
determined from serological analysis. In our study, the fact
that only one stool sample was HEV-positive might be
explained by the lower level of excretion of the virus in
stools, the fragility of the virion in the environment, and
technical difﬁculties in concentrating and amplifying the virus
with standard methods. In conclusion, further studies should
combine virological and environmental surveys to determine
the magnitude of the different modes of transmission, in
order to improve guidelines to prevent infections by HAV
and HEV in Egypt.
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Abstract
The molecular epidemiology of human papillomavirus (HPV)
infection in a sample of Greek women (n = 2952, mean age
42.2 ± 13.3 years) was examined. HPV prevalence was 50.7%
(95% conﬁdence interval, 48.8–52.6). The most frequent HPV
types were HPV 53, 51 and 66 (10.2%, 9.4% and 9.3%, respec-
tively). HPV positivity was associated with age, age of sexual
debut, number of sexual partners and duration of sexual rela-
tionship, while marriage or multiparity protected against infec-
tion (all p <0.001). Follow-up of this cohort will assist in
predicting the effect of vaccination with the new HPV vaccines
on future screening with HPV-based tests for cervical cancer.
Keywords: cervical cancer, HPV, HPV vaccines, molecular epi-
demiology, prevalence
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The effects of the introduction of the two new human papil-
lomavirus (HPV) vaccines in cervical screening programmes
are unknown. Adequate knowledge of the local epidemiology
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